ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 47 filers reported holding ONCOCYTE CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,791 | -53.3% | 12,136 | -34.8% | 0.00% | – |
| Q4 2022 | $5,972 | -57.3% | 18,609 | 0.0% | 0.00% | – |
| Q3 2022 | $14,000 | -17.6% | 18,609 | 0.0% | 0.00% | – |
| Q2 2022 | $17,000 | -26.1% | 18,609 | +21.6% | 0.00% | – |
| Q1 2022 | $23,000 | -30.3% | 15,309 | 0.0% | 0.00% | – |
| Q4 2021 | $33,000 | +3200.0% | 15,309 | +6023.6% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | -50.0% | 250 | -5.7% | 0.00% | – |
| Q4 2016 | $2,000 | +100.0% | 265 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 265 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 265 | -15.9% | 0.00% | – |
| Q1 2016 | $1,000 | – | 315 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 2,982,557 | $5,697,000 | 6.44% |
| BROADWOOD CAPITAL INC | 14,716,204 | $28,108,000 | 2.20% |
| PURA VIDA INVESTMENTS, LLC | 5,983,724 | $11,429,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 99,282 | $190,000 | 0.90% |
| P.A.W. CAPITAL CORP | 200,000 | $382,000 | 0.43% |
| Penbrook Management LLC | 215,625 | $412,000 | 0.40% |
| EAM Investors, LLC | 241,769 | $462,000 | 0.10% |
| Private Wealth Partners, LLC | 150,000 | $287,000 | 0.04% |
| Phoenix Holdings Ltd. | 292,275 | $597,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 145,650 | $470,000 | 0.02% |